Stocks To Buy Now

Blog


American Cannabis Partners M&A Strategy Key Component of Growth Plan

  • Report notes that global mergers and acquisition will continue into new year
  • ACP performs months of due diligence before acquiring any properties
  • Company exploring land acquisition, project development strategies for expanding operations to two more states this year
Mergers and acquisitions (M&A) appear to be a key component for companies looking to grow, with a recent 2022 Global M&A Trends Report indicating that M&A will continue in the new year (https://ibn.fm/BWtXR). Contending for first place in the U.S. cannabis industry, American Cannabis Partners (“ACP”) relies on proven strategies such as mergers and acquisitions to strengthen its position in a competitive market. “Through an analysis of M&A deal activity across seven to thirteen sectors, with breakdown for each region, the [Global M&A Trends Report] concludes that we should expect further, unprecedented global growth in 2022,” the article stated. “While the pandemic has continued to impact the wider market and M&A deal terms over the course of 2021, its impact has diminished from the preceding year. Across nearly all regions, practitioners agreed that due diligence was of paramount importance to doing deals in 2021.” Due diligence is a top priority for ACP; on its website, the company notes that it “performs months of due diligence before acquiring any properties. Our sights are set on listings in cannabis friendly states, cannabis population demand, agricultural zoning, available licenses, and market value. Land and equipment are purchased in full to keep American Cannabis Partners debt free, tangible, and liquid available. After acquisitions, cost-effective measures are taken to update and appraise properties to increase market value” (https://ibn.fm/HfswI). ACP CEO Stephen Jordan echoed this philosophy when he noted that the company focuses on “‘assets, assets, assets — and then build(s) the operations out,’ a rare approach in the cannabis industry where most companies create a product first and if something happens where they are unable to make that product, they go under” (https://ibn.fm/qZ0p0). The company recognizes that state and federal regulations can fluctuate wildly, but as a multistate operator, ACP can pivot within the fluctuations of each state’s laws. This focus on maintaining the ability to liquidate, move and survive is a fundamental strategy that allows American Cannabis Partners to protect its shareholders. ACP is in the process of exploring land acquisition and project development strategies for expanding operations to additional states this year. With a total of 12 cannabis licenses, including 20,000 square feet of cultivation licenses in California and 540,000 square feet of cultivation licenses along with one retail license in Michigan, ACP is committed to becoming a leader in the U.S. cannabis industry. For more information, visit the company’s website at www.ACPFarms.com. NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://ibn.fm/ACP

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) Strengthens Position in CTCL Treatment with HyBryte(TM) FLASH Results

September 24, 2025

Soligenix (NASDAQ: SNGX) is continuing to build momentum in its mission to advance HyBryte(TM), a first-in-class treatment for early-stage cutaneous T-cell lymphoma (“CTCL”). That progress is supported by results from its pivotal FLASH trial and its ongoing FLASH 2 confirmatory study. Together, the studies highlight not only the efficacy of synthetic hypericin activated by safe […]

Rotate your device 90° to view site.